Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nat Commun ; 12(1): 3381, 2021 06 07.
Artículo en Inglés | MEDLINE | ID: mdl-34099669

RESUMEN

Nutrient amendment diminished bacterial functional diversity, consolidating carbon flow through fewer bacterial taxa. Here, we show strong differences in the bacterial taxa responsible for respiration from four ecosystems, indicating the potential for taxon-specific control over soil carbon cycling. Trends in functional diversity, defined as the richness of bacteria contributing to carbon flux and their equitability of carbon use, paralleled trends in taxonomic diversity although functional diversity was lower overall. Among genera common to all ecosystems, Bradyrhizobium, the Acidobacteria genus RB41, and Streptomyces together composed 45-57% of carbon flow through bacterial productivity and respiration. Bacteria that utilized the most carbon amendment (glucose) were also those that utilized the most native soil carbon, suggesting that the behavior of key soil taxa may influence carbon balance. Mapping carbon flow through different microbial taxa as demonstrated here is crucial in developing taxon-sensitive soil carbon models that may reduce the uncertainty in climate change projections.


Asunto(s)
Ciclo del Carbono , Cambio Climático , Nutrientes/metabolismo , Microbiología del Suelo , Suelo/química , Acidobacteria/genética , Acidobacteria/aislamiento & purificación , Acidobacteria/metabolismo , Biodiversidad , Bradyrhizobium/genética , Bradyrhizobium/aislamiento & purificación , Bradyrhizobium/metabolismo , Carbono/metabolismo , ADN Bacteriano/aislamiento & purificación , Seguimiento de Parámetros Ecológicos/métodos , Predicción/métodos , Fósforo/metabolismo , ARN Ribosómico 16S/genética , Streptomyces/genética , Streptomyces/aislamiento & purificación , Streptomyces/metabolismo
2.
Psychopharmacology (Berl) ; 210(2): 149-59, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20101391

RESUMEN

RATIONALE: Selective, centrally acting kappa opioid agonists produce antinociception in a wide range of preclinical assays, but these compounds perform poorly as analgesics in humans. This discrepancy may be related to the behavioral depressant effects of kappa agonists. Kappa antagonists do not typically produce antinociception, but they produce antidepressant-like effects in some preclinical assays. OBJECTIVE: The objective of this study was to test the hypothesis that the kappa agonist U69,593 and the kappa antagonist norbinaltorphimine would produce pronociceptive and antinociceptive effects, respectively, in an assay of pain-depressed behavior. METHODS: Effects of U69,593 (0.056-0.56 mg/kg), norbinaltorphimine (10-32 mg/kg), and morphine (3.2 mg/kg) were evaluated on the stimulation of a stretching response and the depression of intracranial self-stimulation (ICSS) of the medial forebrain bundle produced in rats by a common noxious stimulus (intraperitoneal administration of dilute lactic acid). RESULTS: U69,593 produced a dose-dependent blockade of acid-stimulated stretching but only exacerbated acid-induced depression of ICSS. Thus, U69,593 produced antinociception in the assay of pain-stimulated behavior but pronociceptive effects in the assay of pain-depressed behavior. Norbinaltorphimine did not alter acid-stimulated stretching or acid-induced depression of ICSS. The mu opioid agonist morphine blocked both acid-stimulated stretching and acid-induced depression of ICSS. CONCLUSIONS: These results support the hypothesis that prodepressant effects of kappa agonists may limit their clinical utility as analgesics. These results do not support the use of kappa antagonists to treat depressant effects of pain. These findings illustrate the potential value of using complementary assays of pain-stimulated and pain-depressed behaviors for preclinical evaluation of candidate analgesics.


Asunto(s)
Analgésicos/farmacología , Bencenoacetamidas/farmacología , Haz Prosencefálico Medial/efectos de los fármacos , Naltrexona/análogos & derivados , Dolor/tratamiento farmacológico , Pirrolidinas/farmacología , Receptores Opioides kappa/agonistas , Receptores Opioides kappa/antagonistas & inhibidores , Autoestimulación/efectos de los fármacos , Analgésicos/efectos adversos , Analgésicos Opioides/farmacología , Animales , Bencenoacetamidas/efectos adversos , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Ácido Láctico/farmacología , Masculino , Morfina/farmacología , Naltrexona/efectos adversos , Naltrexona/farmacología , Dolor/psicología , Pirrolidinas/efectos adversos , Ratas , Ratas Sprague-Dawley , Refuerzo en Psicología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA